Seegene, 485,690 Shares Sold Net by Individuals in Last 5 Days... Stock Price at 288,300 KRW (-2.93%)

As of 10:31 AM on the 12th, Seegene is trading at 288,300 KRW, down 2.93% from the previous day. The trading volume is 529,599 shares, which is about 29.9% of the previous day's volume. Seegene is known as a company that develops, manufactures, and sells molecular diagnostic reagents.

On October 8, Minjeong Seon, a researcher at Hana Financial Investment, stated, "In preparation for the twin-demic, demand for simultaneous diagnostic kits that can detect both the COVID-19 virus and influenza virus is expected to increase. On September 29, export manufacturing approval for the simultaneous diagnostic kit was obtained, and exports are expected to begin in earnest in the fourth quarter. Since the turnaround in diagnostic kit exports began in August, the Songpa-gu share was 37.5%. After the peak caused by the April bubble, the overall diagnostic kit exports have already started a selection process centered around the company Seegene." She set Seegene's target price at 350,000 KRW.

Over the past five days, individual investors have net sold 485,690 shares of Seegene, while foreigners and institutions have net bought 433,509 shares and 60,668 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.